Does expression of the retrogene UTP14c in the ovary pre-dispose women to ovarian cancer?

Medical Hypotheses

Volumn 78, Issue 4, 2012, Pages 446-449

  Rohozinski, Jan ^a,b   Edwards, Creighton L ^b   Anderson, Matthew L ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MIR 145; MYC PROTEIN; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; UTP14C PROTEIN;

APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY; OVARY CANCER; OVARY CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS; OVARY; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84858161043     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.12.016     Document Type: Article

References (30)

1. Wang P.J. X chromosomes, retrogenes and their role in male reproduction. Trends Endocrinol Metab 2004, 15:79-83.
2. Shiao M.S., Khil P., Camerini-Otero R.D., Shiroishi T., Moriwaki K., Yu H.T., et al. Origins of new male germ-line functions from X-derived autosomal retrogenes in the mouse. Mol Biol Evol 2007, 24:2242-2253.
3. Vinckenbosch N., Dupanloup I., Kaessmann H. Evolutionary fate of retroposed gene copies in the human genome. Proc Natl Acad Sci USA 2006, 103:3220-3225.
4. Bradley J., Baltus A., Skaletsky H., Royce-Tolland M., Dewar K., Page D.C. An X-to-autosome retrogene is required for spermatogenesis in mice. Nat Genet 2004, 36:872-876.
5. Rohozinski J., Bishop C.E. The mouse juvenile spermatogonial depletion (jsd) phenotype is due to a mutation in the X-derived retrogene, mUtp14b. Proc Natl Acad Sci USA 2004, 101:11695-11700.
6. Rohozinski J., Lamb D.J., Bishop C.E. UTP14c is a recently acquired retrogene associated with spermatogenesis and fertility in man. Biol Reprod 2006, 74:644-651.
7. Danshina P.V., et al. Phosphoglycerate kinase 2 (PGK2) is essential for sperm function and male fertility in mice. Biol Reprod 2010, 82(1):136-145.
8. Rohozinski J., Anderson M.L., Broaddus R.E., Edwards C.L., Bishop C.E. Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers. PLoS One 2009, 4:e5064.
9. Dragon F., Gallagher J.E., Compagnone-Post P.A., Mitchell B.M., Porwancher K.A., Wehner K.A., et al. A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA biogenesis. Nature 2002, 417:967-970.
10. Hu L., Wang J., Liu Y., Zhang Y., Zhang L., Kong R., et al. A small ribosomal subunit (SSU) processome component, the human U3 protein 14A (hUTP14A) binds p53 and promotes p53 degradation. J Biol Chem 2011, 286:3119-3128.
11. A.f. http://www.cancer.gov/cancertopics/types/ovarian.
12. Edson M.A., Nagaraja A.K., Matzuk M.M. The mammalian ovary from genesis to revelation. Endocr Rev 2009, 30:624-712.
13. Brady C.A., Attardi L.D. P53 at a glance. J Cell Sci 2010, 123:2527-2532.
14. Wang SY, Yu QJ, Zhang RD, Liu B. Core signaling pathways of survival/death in autophagy-related cancer networks. Int J Biochem Cell Biol 2011.
15. Maddocks O.D., Vousden K.H. Metabolic regulation by p53. J Mol Med (Berl) 2011, 89:237-245.
16. Bohlig L., Rother K. One function-multiple mechanisms: the manifold activities of p53 as a transcriptional repressor. J Biomed Biotechnol 2011, 2011:464916.
17. Lindenboim L., Borner C., Stein R. Nuclear proteins acting on mitochondria. Biochim Biophys Acta 2011, 1813:584-596.
18. Tsvetkov P., Reuven N., Shaul Y. Ubiquitin-independent p53 proteasomal degradation. Cell Death Differ 2010, 17:103-108.
19. Lavin M.F., Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ 2006, 13:941-950.
20. Boulon S., Westman B.J., Hutten S., Boisvert F.M., Lamond A.I. The nucleolus under stress. Mol Cell 2010, 40:216-227.
21. Suzuki K., Matsubara H. Recent advances in p53 research and cancer treatment. J Biomed Biotechnol 2011, 2011:978312.
22. Network TCGAR. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-15.
23. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., et al. P53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009, 106:3207-3212.
24. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
25. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
26. Sachdeva M., Mo Y.Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010, 70:378-387.
27. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658.
28. Wolfer A., Ramaswamy S. MYC and metastasis. Cancer Res 2011, 71:2034-2037.
29. Boominathan L. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Cancer Metastasis Rev 2010, 29:613-639.
30. Mallanna S.K., Rizzino A. Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev Biol 2010, 344:16-25.